Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease

Respiration

Volumn 84, Issue 1, 2012, Pages 36-43

  Almagro, Pedro ^a   Salvad, Meritxell ^a   Garcia Vidal, Carolina ^a   Rodrguez Carballeira, Mnica ^a   Cuchi, Eva ^a   Torres, Juan ^a   Ll Heredia, Josep ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Acute exacerbation; Chronic obstructive pulmonary disease; Hospitalization; Mortality; Pseudomonas aeruginosa

Indexed keywords

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS INFECTION; QUALITY OF LIFE; SPIROMETRY; SPUTUM CULTURE;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROGNOSIS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPIROMETRY; SPUTUM;

EID: 84863503997     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000331224     Document Type: Article

References (32)

1. Almagro P, Barreiro B, Ochoa de Echagüen A, Quintana S, Rodríguez Carballeira M, Heredia JL, Garau J: Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006; 73: 311-317. (Pubitemid 43725788)
2. Connors AF, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA: Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996; 154: 959-967.
3. Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL, Garau J: Mortality after hospitalization for COPD. Chest 2002; 121: 1441-1448. (Pubitemid 34499653)
4. Groenewegen KH, Schols AM, Wouters EF: Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-467. (Pubitemid 37000120)
5. Sanjaume M, Almagro P, Rodríguez-Carballeira M, Barreiro B, Heredia JL, Garau J: Post-hospital mortality in patients re-admitted due to COPD. Utility of BODE index (in Spanish). Rev Clin Esp 2009; 209: 364-370.
6. Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M: Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999; 116: 40-46. (Pubitemid 29340258)
7. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H: Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113: 1542-1548. (Pubitemid 28307157)
8. Garcia-Vidal C, Almagro P, Romaní V, Rodríguez-Carballeira M, Cuchi E, Canales L, Blasco D, Heredia JL, Garau J: Pseudomonas aeruginosa in patients hospitalized for COPD exacerbation. A prospective study. Eur Respir J 2009; 34: 1072-1078.
9. Montero M, Domínguez M, Orozco-Levi M, Salvadó M, Knobel H: Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study. Infection 2009; 37: 16-19.
10. Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A: Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005; 165: 891-897. (Pubitemid 40563235)
11. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012. (Pubitemid 38269277)
12. Angrill J, Agustí C, de Celis R, Rañó A, Gonzalez J, Solé T, Xaubet A, Rodriguez-Roisin R, Torres A: Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002; 57: 15-19. (Pubitemid 34081538)
13. Patel IS, Vlahos I, Wilkinson TM, Lloyd-Owen SJ, Donaldson GC, Wilks M, Reznek RH, Wedzicha JA: Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 400-407. (Pubitemid 39214614)
14. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931. (Pubitemid 41598207)
15. Halpin D: Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena. COPD 2008; 5: 187-200. (Pubitemid 351892734)
16. Global Obstructive Lung Disease (GOLD). Updated 2008. http://www.goldcopd.org/.
17. Schols AM, Slangen J, Volovics L, Wouters EF: Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1791-1797.
18. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T: Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-549.
19. Nishimura K, Izumi T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440. (Pubitemid 34499652)
20. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R: Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-2800. (Pubitemid 28052790)
21. Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C: Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7: 109.
22. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P: Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60-67. (Pubitemid 46072408)
23. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Batlles J, Antó JM: Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-685. (Pubitemid 34971850)
24. Roche N, Kouassi B, Rabbat A, Mounedji A, Lorut C, Huchon G: Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration 2007; 74: 19-25. (Pubitemid 46012444)
25. Renom F, Yáñez A, Garau M, Rubí M, Centeno MJ, Gorriz MT, Medinas M, Ramis F, Soriano JB, Alvar Agustí: Prognosis of COPD patients requiring frequent hospitalization: role of airway infection. Respir Med 2010; 104: 840-848.
26. de Bentzmann S, Roger P, Puchelle E: Pseudomonas aeruginosa adherence to remodelling respiratory epithelium. Eur Respir J 1996; 9: 2145-2150. (Pubitemid 26333558)
27. Goldberg JB, Hancock RE, Parales RE, Loper J, Cornelis P: Pseudomonas 2007. J Bacteriol 2008; 190: 2649-2662. (Pubitemid 351508165)
28. Gibson RL, Burns JL, Ramsey BW: Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 918-951. (Pubitemid 37267172)
29. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S: Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 853-860. (Pubitemid 351600663)
30. Martínez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL: Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infec Dis 200; 47: 1526-1533.
31. Almagro P, López García F, Cabrera F, Montero L, Morchón D, Díez J, Soriano J; Grupo Epoc De La Sociedad Española De Medicina Interna: Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010; 104: 253-259.
32. Osthoff M, Leuppi JD: Management of chronic obstructive pulmonary disease patients after hospitalization for acute exacerbation. Respiration 2010; 79: 255-261.